Cited by 143Cancer Cells and MetastasisImmunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers

Emerging Role of Lymphocyte Antigen-6 Family of Genes in Cancer and Immune Cells

Open access
Upadhyay, Geeta·2019·Frontiers in Immunology

Abstract

Stem Cell Antigen-1 (Sca-1/Ly6A) was the first identified member of the Lymphocyte antigen-6 (Ly6) gene family. Sca-1 serves as a marker of cancer stem cells and tissue-resident stem cells in mice. The Sca-1 gene is located on mouse chromosome 15. While a direct homologue of Sca-1 in humans is missing, human chromosome 8 - the syntenic region to mouse chromosome 15 - harbors several genes containing the characteristic domain known as LU domain. The function of the LU domain in human LY6 gene family is not yet defined. The LY6 gene family proteins are present on human chromosome 6. 8, 11 and 19. The most interesting of these genes are located on chromosome 8q24.3, a frequently amplified locus in human cancer. Human LY6 genes represent novel biomarkers for poor cancer prognosis and are required for cancer progression in addition to playing an important role in immune escape. Although the mechanism associated with these phenotypes is not yet clear, it is timely to review the current literature in order to address the critical need for future advancements in this field. This review will summarize recent findings which describe the role of human LY6 genes - LY6D, LY6E, LY6H, LY6K, PSCA, LYPD2, SLURP1, GML, GPIHBP1 and LYNX1; and their orthologues in mice at chromosome 15.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2019.00819

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 69 · Cited by 143

Authors
Upadhyay, G.
Affiliations
Uniformed Services University of the Health Sciences (US)
Corresponding author
Upadhyay, Geeta
Venue
Frontiers in Immunology
Published
2019-04-24
Volume
10
Pages
819-819
ISSN
1664-3224 (ISSN-L)
OpenAlex
W2934533555
Cited by
143
References
69
Citations by year
2026: 10 · 2025: 22 · 2024: 29 · 2023: 24 · 2022: 27 · 2021: 17 · 2020: 12 · 2019: 1
FWCI
1.36
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Immunology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Uniformed Services University of the Health Sciences (R01CA227694)
  • National Cancer Institute (R01CA227694)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Keywords
cancer stem cells, tissue-resident stem cells, chromosome 15, tumor markers, cancer prognosis, tumor progression, immune evasion, immune cells
MeSH terms
Ataxin-1, Animals, Disease Susceptibility, Multigene Family, Humans, Lymphocytes, Neoplasms, Organ Specificity, Gene Expression Regulation, Neoplastic, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review